Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Sputnik V Demonstrates 97.2% Efficacy And High Safety Profile Against COVID During The Vaccination Campaign In Belarus 2021-09-15 16:00
US Patent and Trademark Office grants new patent for DEP® cabazitaxel, one of Starpharma's phase 2 clinical-stage cancer treatments 2021-09-15 15:27
CStone received China NMPA IND approval for CS2006/NM21-1480, a PD-L1/4-1BB/HSA multi-specific antibody, marking further expansion of its Pipeline 2.0 2021-09-15 08:30
New Therapy to Treat Advanced Small Cell Lung Cancer Approved for Australian Patients 2021-09-14 18:57
BioVaxys Bioproduction Partner WuXi Biologics Completes Synthesis Of Recombinant SARS-CoV-2 s-proteins for BVX-0320 and CoviDTH Programs 2021-09-14 15:00
Jemincare group has completed the Phase I clinical trial of its anti-SARS-CoV-2 neutralizing antibody JMB2002 2021-09-14 11:43
Eleva Reaches Industrial Production Scale and Prepares for Clinical Development of Factor H 2021-09-14 10:30
CStone presents updated data from registrational clinical study of sugemalimab in patients with stage IV NSCLC in an oral presentation at IASLC 2021 WCLC 2021-09-14 08:30
Global Investors Invest in Etana 2021-09-14 08:00
PharmAbcine to Participate in ACCESS CHINA Biotech Forum 2021-09-13 20:00
I-Mab Added to FTSE ESG Index Series 2021-09-13 20:00
RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients with South African Approval 2021-09-13 19:00
Hummingbird Bioscience Announces US FDA Clearance of IND for First-in-Human Phase 1 Trial of HMBD-002 in Patients with Advanced Solid Tumors 2021-09-13 17:00
Everest Medicines Enters into Comprehensive Agreements with Providence Therapeutics to Advance mRNA Vaccines and Therapies, including COVID-19 Vaccines, in Asia Emerging Markets 2021-09-13 17:00
Samsung Biologics Joins Frontier 1.5D Project as part of 2050 Carbon Neutral Initiative 2021-09-13 12:41
Kazia Therapeutics to Present at HC Wainwright 23rd Annual Global Investment Conference 2021-09-11 00:30
Senhwa Announces First Patient Successfully Dosed in Phase 1b Expansion Study of Pidnarulex to Treat Solid Tumors with Specific Homologous Recombination Gene Mutations 2021-09-10 19:00
Cytiva triples single-use consumables capacity in China 2021-09-10 16:33
Yuyu Pharma Receives ISO 37001 Anti-Bribery Management System Certification 2021-09-09 21:00
Clover Biopharmaceuticals Receives Pharmaceutical Manufacturing Permit from Zhejiang Medical Products Administration to Produce COVID-19 Vaccine 2021-09-09 19:51
1 223 224 225 226 227 413